TR200200930T2 - Katyonik dosper virosomlar - Google Patents

Katyonik dosper virosomlar

Info

Publication number
TR200200930T2
TR200200930T2 TR2002/00930T TR200200930T TR200200930T2 TR 200200930 T2 TR200200930 T2 TR 200200930T2 TR 2002/00930 T TR2002/00930 T TR 2002/00930T TR 200200930 T TR200200930 T TR 200200930T TR 200200930 T2 TR200200930 T2 TR 200200930T2
Authority
TR
Turkey
Prior art keywords
cationic
virosomes
relates
dosper
lipids
Prior art date
Application number
TR2002/00930T
Other languages
English (en)
Inventor
Rudolf Walti Ernst
Gl�Ck Reinhard
Klein Peter
Original Assignee
Nika Health Products Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/414,872 external-priority patent/US6210708B1/en
Application filed by Nika Health Products Limited filed Critical Nika Health Products Limited
Publication of TR200200930T2 publication Critical patent/TR200200930T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Bu bulus bir non-sendai viral hemaglutinin olan en az bir aktif füzojenik peptid ihtiva eden bir katyonik virozom ile ilgili olup, burada virozom membrani toplam lipidlere göre agirlik bazinda %5 ila %30 oraninda 1,3-dioleoiloksi-2(6-karboksi-spermil)-propilamidi (DOSPER) fosfatidilkolin (PC) veya bunu bir türevi ve opsiyonel olarakda fosfatidiletanolamin (PE) ve/veya sair katyonik lipidler ile kombinasyon halinde ihtiva eder. Virozomlar negatif sarjli maddelerin ve özellikle de nükleik asit bilesiklerinin, hedef hücrelere verilmesinde çok randimanli olur. Bu bulus, ayni zamanda,virozomlarin imaline yönelik bir metod ve bunlarin diyagnostik , kozmetik, tibbi veya bilimsel gayelerle kullanimlari ile ilgilidir.
TR2002/00930T 1999-10-08 2000-09-29 Katyonik dosper virosomlar TR200200930T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/414,872 US6210708B1 (en) 1996-05-08 1999-10-08 Cationic virosomes as transfer system for genetic material

Publications (1)

Publication Number Publication Date
TR200200930T2 true TR200200930T2 (tr) 2002-08-21

Family

ID=23643351

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00930T TR200200930T2 (tr) 1999-10-08 2000-09-29 Katyonik dosper virosomlar

Country Status (19)

Country Link
EP (1) EP1217990B1 (tr)
JP (1) JP2003512306A (tr)
KR (1) KR100869195B1 (tr)
AT (1) ATE258428T1 (tr)
AU (1) AU778399B2 (tr)
CA (1) CA2388053A1 (tr)
CO (1) CO5280052A1 (tr)
CZ (1) CZ20021216A3 (tr)
DE (1) DE60008006T2 (tr)
DK (1) DK1217990T3 (tr)
ES (1) ES2215073T3 (tr)
HU (1) HUP0202809A2 (tr)
NO (1) NO20021607L (tr)
PE (1) PE20010703A1 (tr)
PL (1) PL355231A1 (tr)
RU (1) RU2002112224A (tr)
SK (1) SK4782002A3 (tr)
TR (1) TR200200930T2 (tr)
WO (1) WO2001026628A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL377161A1 (pl) * 2002-11-21 2006-01-23 Pevion Biotech Ltd. Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki
JP4497894B2 (ja) * 2003-11-07 2010-07-07 明彦 河合 物質導入剤およびその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
DE19521412A1 (de) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
AU710170B2 (en) * 1996-05-08 1999-09-16 Nika Health Products Limited Cationic virosomes as transfer system for genetic material
DE69736692T2 (de) * 1996-07-16 2007-06-14 Archibald James Mixson Kationisches Vehikel: DNS Komplexe und ihre Verwendung in Gentherapie

Also Published As

Publication number Publication date
CA2388053A1 (en) 2001-04-19
CO5280052A1 (es) 2003-05-30
JP2003512306A (ja) 2003-04-02
DK1217990T3 (da) 2004-05-24
EP1217990A1 (en) 2002-07-03
SK4782002A3 (en) 2002-09-10
RU2002112224A (ru) 2004-01-10
PE20010703A1 (es) 2001-07-11
ES2215073T3 (es) 2004-10-01
AU7785000A (en) 2001-04-23
DE60008006D1 (de) 2004-03-04
PL355231A1 (en) 2004-04-05
ATE258428T1 (de) 2004-02-15
KR100869195B1 (ko) 2008-11-18
NO20021607L (no) 2002-06-07
HUP0202809A2 (hu) 2002-12-28
WO2001026628A1 (en) 2001-04-19
AU778399B2 (en) 2004-12-02
KR20020063872A (ko) 2002-08-05
NO20021607D0 (no) 2002-04-05
EP1217990B1 (en) 2004-01-28
DE60008006T2 (de) 2004-09-09
CZ20021216A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
EP1764091A3 (en) Improvements in or relating to amphoteric liposomes
Nguyen et al. Nucleic acid delivery: the missing pieces of the puzzle?
TR199800046A2 (tr) Aktif maddeler yaratilmasi için nükleik asit olusumu.
EP2335687B1 (en) Use of monoolein as a new auxiliary lipid in lipofection
CA2506593A1 (en) High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them
TR199902731T2 (tr) Kimyasal bilesikler.
ATE256452T1 (de) Formulierungen in form von emulsionen zur verabreichung von nukleinsäuren an zellen
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
Kwon et al. Electrodeless reverse electrodialysis patches as an ionic power source for active transdermal drug delivery
Gad Cationic polypeptide-induced fusion of acidic liposomes
ATE322255T1 (de) Polyamid-oligomere
ATE301709T1 (de) Lipidabkömmlinge von pentaerythritol
NZ332666A (en) Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy
WO2005000240A3 (en) Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
WO2006065960A3 (en) Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
BR112022000925A2 (pt) Nanopartículas de rna multilamelares
WO2003102150A3 (en) Multi-functional polyamines for delivery of biologically-active polynucleotides
JP2009203174A (ja) タンパク質−リポソーム複合体を含有するイオントフォレーシス用組成物
Škalko et al. pH-sensitive liposomes for receptor-mediated delivery to chicken hepatoma (LMH) cells
ATE331739T1 (de) Polyanionische polymere mit verbesserter fusogenfähigkeit
ATE258428T1 (de) Kationische dosper virosomen
DE69922248D1 (de) Integriertende protein-dna cochleateformulierungen und verfahren zur transformation von zellen
Villalobo et al. Proton countertransport by the reconstituted erythrocyte Ca2+-translocating ATPase: evidence using ionophoretic compounds
Asayama et al. Structure-activity relationship between Zn2+-chelated alkylated poly (1-vinylimidazole) and gene transfection
WO1996040627A3 (en) Thiocationic lipids, pharmaceutical compositions and methods of use thereof